Injection Articles
Immutep completes Ph I with ImmuFact
5 June 2006
Teva sets up in Japan
29 May 2006
Genzyme's gene therapy assessed in PAD
22 May 2006
OSI's Macugen sees strong data at ARVO 2006
15 May 2006
Questcor licenses US Doral rights for $4M
15 May 2006
UCB submits Cimzia MAA to EMEA
15 May 2006
Serono's US CLARITY trial starts enrolling
15 May 2006
IFPMA members work on avian flu vaccs
15 May 2006
FDA approves Dacogen for MDS
8 May 2006
Funding helps shed light on medical research
8 May 2006
Japan stock market week to May 1, 2006
8 May 2006
Roche/GSK launches Bonviva
8 May 2006
Lilly/Alkermes begin PhIII insulin study
8 May 2006
Nautilus: oral protein drugs on the horizon?
1 May 2006
Preotact gets EU Marketing approval
1 May 2006
Eli Lilly profit up 6% in 1st-qtr 2006
1 May 2006
NICE says inhaled insulin "too expensive" for UK, Pfizer appeals to health professionals
24 April 2006
Cytogen: "less Quadramet toxicity via ILP"
17 April 2006
Pfizer advises label changes on Macugen
17 April 2006
Lonza to invest $200M in Chinese operations
17 April 2006
High-dose Copaxone effective in RRMS trial
17 April 2006
Serono submits Rebif sBLA to US FDA
10 April 2006
EU approves Roche/GSK's Bonviva IV
3 April 2006
New French biomed center operational
3 April 2006
Vernalis' 2005 losses rise to L32.8M
27 March 2006
First EU approval for ALK-Abello's Grazax
27 March 2006
MGI Pharma initiates Ph III Aquavan program
27 March 2006
Coratus Genetics suspends VEGF trial
20 March 2006
German group reports new RA therapy
20 March 2006
US FDA "approvable letter" for NPS' Preos
20 March 2006
OSI Pharma sees 2005 losses fall to $157.1M
20 March 2006
Sanofi-Aventis launches Apidra insulin in USA
13 March 2006
Alcon withdraws EU Retaane MAA
13 March 2006
Bayer's income reaches 1.59B in 2005, up 133%
13 March 2006
Pfizer/OSI's Macugen gets OK in Europe
27 February 2006
Acambis' C difficile vacc shows promise in study
27 February 2006
FDA accepts sNDA on GSK's Hycamtin
27 February 2006
Positive results for SCOLR's ondansetron CR
27 February 2006
ViRexx completes $12M financing
20 February 2006
APP gets FDA ANDA OK for ceftriaxone
20 February 2006
FDA issues "advisory" on Bayer's Trasylol
20 February 2006
Lilly launches Humalog rapid insulin in USA
13 February 2006
Private funding for CureVac
13 February 2006
Akzo 2005 income rises 1.7%, Organon gains
13 February 2006
EC approves Pfizer's Macugen for wet AMD
13 February 2006
CMPH gives nod to UCB's Keppa for EU appro
13 February 2006
Genzyme gets label change for Thyrogen
6 February 2006
FDA approves Pfizer's Exubera inhaled insulin
6 February 2006
Bonviva injection set for EU approval
6 February 2006
Lilly swings to 4th-qtr 2005 profit
6 February 2006
Oncolytics completes patient follow up in Reolysin trial
30 January 2006
Serono's Gonal-f approved in Japan
30 January 2006
NEJM study finds health risks associated with Bayer's Trasylol
30 January 2006
J&J's 4th-qtr 2005 sales drop 1.1% on low Rx
30 January 2006
Inspire halts ophthalmic drug trials
30 January 2006
Bayer to pay up to $385M for ex-US sale rights to Nuvelo's Ph III thrombolytic, alfimeprase
16 January 2006
FDA approves ZLB Behring's Vivaglobin for PIDD
16 January 2006
Lilly and Alkermes enter oral PTH accord
16 January 2006
FDA approves Roche and GSK's IV Boniva
16 January 2006
Japan stock market week to January 9
16 January 2006
Astellas Pharma's Vaprisol gains FDA approval
9 January 2006
Tercica launches Increlex in USA
9 January 2006
FDA accepts Dacogen NDA as complete response
9 January 2006
Genta completes EMEA filing for Genasense plus chemo
9 January 2006
Amylin buys plant to make Byetta LAR
9 January 2006
Use of stem cells from hair follicles
9 January 2006
New indications in Japan for S-P drugs
9 January 2006
AstraZeneca's Faslodex and Arimidex little different
19 December 2005
Consumer interest in drug delivery can raise compliance; study
19 December 2005
Insmed shares soar on news of US OD designation for Iplex
19 December 2005
Dyax start Ph III trials of angiodema drug
19 December 2005
APP gains FDA appro for azithromycin injectable
19 December 2005
Spectrum initiates Ph II satraplatin trials
19 December 2005
Supergen/MGI to enter Dacogen for new indications
19 December 2005
Tercica submits Increlex MAA
19 December 2005
Bayer initiates Ph III Trasylol study
19 December 2005
Halozyme/Baxter get FDA appro for Hylenex
12 December 2005
Sanofi's Taxotere gets priority review for advanced gastric cancer
12 December 2005
Organon USa to distribute Sanofi-Aventis' Anzemet
12 December 2005
Strong animal data for KDI in PD
5 December 2005
Antares to supply injectables to Teva
5 December 2005
ISTA publishes Vitrase Ph II trial results
12 September 2005
VaxGen publishes results of smallpox vaccine study
12 September 2005
Tercica responds to citizen petition
5 September 2005
Baxter gets FDA go ahead for Ceftriaxone
5 September 2005
FDA OKs Tercica's Increlex for primary IGFD
5 September 2005
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
